BACKGROUND A secondary rise of intracellular Ca 2þ (Ca i ) and an upregulation of apamin-sensitive K þ current (I KAS ) are characteristic findings of failing ventricular myocytes. We hypothesize that apamin, a specific I KAS blocker, may induce torsades de pointes (TdP) ventricular arrhythmia from failing ventricles exhibiting secondary rises of Ca i .
Introduction
Ventricular arrhythmia is a major cause of death in patients with heart failure (HF). 1 Multiple randomized clinical trials [2] [3] [4] conducted in patients with HF documented increased ventricular arrhythmias or mortality in patients randomized to the drug treatment arm, suggesting that HF predisposes patients to drug-induced arrhythmia. A recent study confirmed that there is enhanced sensitivity to drug-induced QT interval lengthening in patients with HF owing to left ventricular (LV) systolic dysfunction. 5 The mechanisms by which HF increases the risk of drug-induced arrhythmia and reduces drug safety remain poorly understood. Previous studies showed that HF is associated with the downregulation of multiple K þ currents 6, 7 but the upregulation of apaminsensitive K þ current (I KAS ) conducted through the small conductance Ca 2þ activated K þ (SK) channels. 8 Drugs that block these K þ currents may reduce repolarization reserve, prolong action potential duration (APD), and increase propensity of ventricular arrhythmia. The upregulation of I KAS in failing ventricles was recently reproduced by Bonilla et al 9 in a canine model of HF. In addition to I KAS upregulation, failing ventricular myocytes are known to develop a slow secondary rise of intracellular Ca 2þ (Ca i ) that prolongs the Ca i transient duration. 10 The prolonged availability of Ca 2þ may activate the I KAS to counterbalance the downregulation of other K þ currents, thereby maintain repolarization reserve and prevent ventricular arrhythmias in HF. If this hypothesis is correct, then blocking the I KAS by apamin should reduce the repolarization reserve and promote ventricular arrhythmias in failing but not normal ventricles. This hypothesis has important implications in drug safety in HF because inadvertent blocking of I KAS by food or drugs may increase the incidence of ventricular arrhythmia and sudden cardiac death. The purpose of the present study was to perform optical mapping studies in failing rabbit ventricles to test the hypotheses that apamin, a specific I KAS blocker, induces early afterdepolarizations (EADs) and torsades de pointes (TdP) ventricular arrhythmias from areas with secondary rises of Ca i in failing ventricles.
Methods

Surgical preparation
Rapid pacing protocol was conducted to induce HF in 7 New Zealand white rabbits. 8, 11 Five normal rabbits were also studied as controls. Echocardiography was performed before and after high-rate pacing. The hearts were harvested and Langendorff perfused with oxygenated 371C Tyrode's solution that includes (in mmol/L) NaCl 125, KCl 4.5, NaHCO 3 24, NaH 2 PO 4 1.8, CaCl 2 1.8, MgCl 2 0.5, dextrose 5.5, and bovine serum albumin 100 mg/L with a pH of 7.40. Cryoablation of atrioventricular (AV) node was then performed to reduce ventricular rate. We performed simultaneous membrane potential (V m ) and Ca i optical mapping according to methods published elsewhere. 12, 13 More detailed descriptions are included in an Online Supplement.
Experimental protocol
Pseudoelectrocardiogram was monitored by using 2 electrodes placed at the left atrium and the right ventricle, respectively. A bipolar electrode was used to pace the right ventricle with an output at 2.5 times the diastolic pacing threshold. Dynamic pacing protocol 14 was performed and the optical signals were mapped at different pacing cycle lengths (PCLs). We started to acquire optical mapping signal after at least 30 paced beats at the same PCL. An S1/ S2/S3 short-long-short pacing protocol (S1 30 beats with S1-S1 300 ms, a long S1-S2 of 1000 or 2000 ms, and an S2-S3 starting from 300 ms and gradually shortened to the ventricular effective refractory period) was used to simulate the electrocardiographic characteristics that initiate the TdP ventricular tachycardia in humans. 15 Apamin (100 nmol/L) was then added to the perfusate, and the protocol was repeated 30 minutes later. Nifedipine (2 mmol/L) was then added in 4 of the 7 failing rabbit hearts to determine whether it prevents the development of TdP. The same protocol was also conducted in 5 normal rabbit hearts for comparison.
Data analysis
APD 80 was measured at the level of 80% repolarization of APD, and mean APD 80 was calculated for all available ventricular pixels. A secondary rise of Ca i is defined as the spontaneous increase in Ca i at the downslope of the primary Ca i released. 10 Continuous variables are expressed as mean [95% confident interval]. Paired Student t tests were used to compare continuous variables measured at baseline and during apamin infusion. Comparison of prevalence of EAD inducibility between baseline and during apamin infusion was performed by using paired McNemar test. A P r .05 was considered statistically significant. 
Results
Induction of HF
Effects of apamin on QT interval and ventricular arrhythmias in failing ventricles
Apamin significantly prolonged corrected QT (QTc) interval during spontaneous escape rhythm. The QTc interval was 337 [313-360] ms at baseline and 410 [381-439] ms after applying 100 nmol/L of apamin (P ¼ .01). Figure 1A shows an example of QT prolongation after apamin administration. Figure 1B shows the effects of apamin on QTc intervals in all 7 hearts studied. In addition to prolonging QTc intervals, apamin led to the development of EADs in 6 ventricles. The ventricle without EAD had a mean APD of 208 ms (at a PCL of 500 ms), which was within the range of APDs (188-261 ms at a PCL of 500 ms) in ventricles with EADs. Premature ventricular beats (PVBs) were observed in 7 ventricles and polymorphic ventricular tachycardia consistent with TdP in 4 ventricles. 
Activation cycle length and the effects of apamin in failing ventricles
Apamin significantly prolonged APD 80 at all PCLs. The ratio of APD prolongation was larger at long PCLs than at short PCLs. Figure 3A shows representative examples of APD prolongation at different PCLs. Figure 3B shows the mean APD 80 without and with apamin. The color APD 80 maps show the heterogeneous distribution of APD 80 at long PCL, both before and after apamin. Figure 3C shows the ratio of ΔAPD and the baseline APD. Note that the ΔAPD ratio increases with the prolongation of PCL, indicating the importance of I KAS in repolarization at slow heart rates.
Secondary rises of Ca i in failing ventricles were enhanced by apamin
We observed secondary rise of Ca i in all failing ventricles both at baseline and after apamin administration. The area occupied by secondary rises of Ca i was 15.2% [0.25%-27.8%] of the mapped region at baseline and increased to 61.9% [50.6%-73.1%] after apamin administration (P o .001). Figure 4 shows that the secondary rise of Ca i was accentuated in the presence of apamin, along with APD prolongation. Figure 4A shows a representative V m and Ca i traces of a failing ventricle. At long PCL (500 or 1000 ms), apamin administration enhanced secondary Ca i rises and Ca i transient duration. The amplitude of secondary Ca i rises is defined as the largest deviation from a line drawn between the onset and the offset of the secondary Ca i rise ( Figure 4B ). The right panels in Figure 4A show representative secondary Ca i rises and APD 80 maps in the absence and presence of apamin. There were only minimal secondary Ca i rises at baseline, but the secondary Ca i rise became more apparent after adding apamin. The maximum secondary Ca i rises colocalized with the areas with the longest APD (see white arrows in Figure 4A , right panels) and sites of origin of EADs ( Figure 5 ). The secondary Ca i rises were enhanced by apamin and may, but not always, trigger EADs and initiate an episode of TdP. We compared average ( Figure 4C ) and the maximum ( Figure 4D ) secondary Ca i rises of all mapped pixels. The average secondary Ca i rises of all pixels increased significantly (from 0.32% [À0.03% to 0.67%] to Effects of apamin on EAD and ventricular arrhythmia Figure 5A shows the representative examples of optical mapping traces at baseline and after addition of apamin. Without apamin, HF rabbit hearts did not develop TdP arrhythmia ( Figure 5A , baseline) even with short-long-short pacing. Apamin massively prolonged the APD at a PCL of 1000 ms. The corresponding Ca i trace shows a secondary rise of Ca i at the same pixel ( Figure 5A , middle subpanel, blue trace). None of the HF rabbit hearts had EADs without apamin, and 6 (86%) hearts developed EADs or TdP in the presence of apamin (P ¼ .04; Figure 5B ). Figure 5C shows phase maps of the corresponding EAD beats in the spontaneous and the pacing-induced TdPs. Figure 6A shows 2 different traces of spontaneous beats, one without (top subpanel) and the other with (middle subpanel) PVB. Both tracings were from the same pixel indicated by the black asterisk in Figure 6B in failing ventricles after apamin administration. Both episodes had secondary rises of Ca i (green and red lines, respectively). When these 2 traces were superimposed on a third subpanel, it is clear that the one with PVB (red trace) had higher secondary rise of Ca i than the one without PVB (green trace). A corresponding pseudoelectrocardiogram shows that the first QRS complex is followed by a PVB (red arrow). Figure 6D shows the phase, V m , and Ca i maps at the time of PVB onset. An arrow on the V m map points to the initial propagation, which corresponds to the light blue (change in phase) in frame 617 of the phase map. Figure 6C shows the direction of propagation. The results further support an association between the amplitude of secondary Ca i rises and the development of PVBs.
Effects of nifedipine
We tested the effects of nifedipine on apamin-enhanced secondary Ca i rises in 4 of the 7 failing rabbit hearts. Nifedipine (2 mmol/L) shortened APD 80 and reduced the slope of the primary rise of Ca i (ie, Ca release triggered by 
Effects of apamin on nonfailing rabbit ventricles
We also tested apamin effect on 5 nonfailing (control) rabbit hearts with AV block. Apamin did not prolong APD 80 significantly at short (200 and 300 ms) PCLs ( Figures 8A  and 8B ), but it increased APD 80 by 25% at long PCLs (278 [227-328] ms to 346 [275-427] ms at a PCL of 1000 ms; P ¼ .04). The magnitude of APD 80 prolongation ( Figure 8B ) was much smaller than in the failing ventricles ( Figure 3B ). The ΔAPD 80 ratio ( Figure 8B ) was also less than that in failing ventricles ( Figure 3C ). Apamin induced secondary rises of Ca i in 1 of the 5 nonfailing ventricles at a PCL of 500 ms. No EADs or TdP were observed in that or other ventricles either before or after apamin.
Discussion
Importance of ventricular rate on the I KAS As previously reported, apamin did not significantly prolong APD at a PCL of 500 ms. 9, 16, 17 However, when the PCL is lengthened to 1000 ms, even normal ventricles showed significant APD prolongation after apamin administration. According to modeling and experimental studies, 18 longer diastolic intervals are associated with a higher availability of L-type Ca 2þ current (I Ca,L ) and longer Ca i transient duration. The persistent trans-sarcolemmal Ca 2þ flow through L-type Ca 2þ channels may facilitate the SK channel activation. Therefore, blocking SK channels at long PCL prolongs APD.
Secondary rises of Ca i
The reduced initial phase of Ca 2þ transient, the slowed decay of Ca i transient, and secondary rises of Ca i are commonly observed in cardiomyocytes from failing ventricles 10 but may also be present during bradycardia. 19 HF reduces the initial phase of Ca 2þ transient, which in turn reduces Ca 2þ -induced inactivation of the I Ca,L . As repolarization continues, the driving force for Ca 2þ entry increases, which promotes greater Ca 2þ entry through already opened L-type Ca 2þ channels, leading to additional sarcoplasmic reticulum Ca 2þ release during the latter phase of the plateau. The increased Ca 2þ can activate sodium-calcium exchangers to prolong APD and to promote EADs. I KAS in failing ventricles serves to counterbalance the APD prolonging effects of the secondary rises of Ca i . I KAS blockade, especially during bradycardia, removes this built-in counterbalance, leading to excessively prolonged APD, PVBs, and TdP arrhythmia. 
I KAS and drug safety
I KAS upregulation is a mechanism by which failing ventricles maintain repolarization reserve and prevent afterdepolarizations especially in myocytes with a secondary rise of Ca i and prolonged Ca i transient duration. The importance of I KAS in human ventricular repolarization is supported by our recent study 20 that showed apamin-prolonged APD in failing human ventricular cells by a mean of 11.8%. In addition to apamin, previous studies have shown that anesthetic agents such as butanol, ethanol, ketamine, lidocaine, and methohexital block recombinant SK2 channel currents. 21 In addition, quinine, quinidine, d-tubocurarine, tetraethylammonium chloride, and 4-aminopyridine are I KAS blockers. 22 Preliminary investigation from our laboratory indicates that amiodarone is an effective I KAS blocker. 23 It is possible that further investigations will discover the SK blocking action of many other drugs used in treating patients with HF. Systematic study is necessary to determine the effects of drugs or chemicals on I KAS to improve the drug safety in patients with HF.
Study limitations
In addition to blocking SK currents, apamin blocks the fetal I Ca,L . 24 If there is significant blockade of I Ca,L in rabbit ventricles, then apamin should have suppressed EADs. The fact that ventricular arrhythmias are induced by apamin suggests that either apamin is not a significant I Ca,L blocker or the EAD is not a mechanism of these arrhythmias. Therefore, we added nifedipine, which eliminated EADs owing to its impact on I Ca,L . These findings further support that the EAD is a mechanism of apamin-induced arrhythmia. Other than I Ca,L blockade, apamin is thought to be a highly selective blocker of SK currents. [25] [26] [27] We propose that the results of the present study are best explained by the SK current inhibition.
Summary and clinical significance
HF is a major risk factor for drug-induced ventricular arrhythmias. 28 I KAS , the only K current known to be upregulated in HF, 8 may have a protective role in the failing ventricle, and efforts (intentional or secondary to off-target drug actions) to suppress this current may have proarrhythmic consequences. We showed in the present study that I KAS blockade in HF ventricles results in EADs, PVBs, and TdP from areas with secondary rises of Ca i . These findings indicate that I KAS is important in maintaining repolarization reserve and preventing TdP in HF ventricles. Better understanding the drug effects on I KAS may be important in the prevention of sudden death in this patient population. 
